In a filing, Dexcom Inc revealed its Officer MICHAEL BROWN acquired Company’s shares for reported $41400.0 on Jun 16 ’25. In the deal valued at $82.80 per share,500 shares were bought.
Then, FOLETTA MARK G bought 2,750 shares, generating $227,700 in total proceeds.
Before that, AUGUSTINOS NICHOLAS bought 6,290 shares. Dexcom Inc shares valued at $546,664 were divested by the Director at a price of $86.91 per share.
Truist initiated its Dexcom Inc [DXCM] rating to a Buy in a research note published on June 16, 2025; the price target was $102. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in late May with a ‘”a Buy”‘ rating. Mizuho began covering DXCM with “an Outperform” recommendation on April 10, 2025. Redburn Atlantic revised its rating on February 03, 2025. It rated DXCM as “a Buy” which previously was an “a Neutral”.
Price Performance Review of DXCM
On Monday, Dexcom Inc [NASDAQ:DXCM] saw its stock jump 1.23% to $83.00. Over the last five days, the stock has lost -3.13%. Dexcom Inc shares have risen nearly 6.72% since the year began. Nevertheless, the stocks have fallen -29.18% over the past one year. While a 52-week high of $117.91 was reached on 02/18/25, a 52-week low of $57.52 was recorded on 04/04/25.
Levels Of Support And Resistance For DXCM Stock
The 24-hour chart illustrates a support level at 82.27, which if violated will result in even more drops to 81.55. On the upside, there is a resistance level at 83.71. A further resistance level may holdings at 84.43.
